12/11/2025 9:20:39 PM Antitrust Risks and Compliance Strategies in Intellectual Property Portfolio Management By Kate Gehl Richard Lee Ellen Matheson Kitty Young +1 more... Show less This article analyzes how intellectual property portfolio management can simultaneously promote innovation and present potential...
12/4/2025 3:50:10 PM FDA Guidance on Biosimilars Highlights Glycosylation Profiling and Increases the Strategic Value of Patents Covering Antibodies Defined by Glycosylation By Oyvind Dahle FDA’s September 2025 guidance requires detailed characterization of posttranslational modifications (PTMs), particularly glycosylation,...
12/2/2025 7:23:09 PM Seeking Grace: Pursuing Method of Treatment Claims in View of Clinical Trial Related Disclosures By Cara Mosley This article was originally published in the AIPLA Chemical Practice Chronicles Fall 2025 newsletter and is republished here with...
12/1/2025 4:02:10 PM USPTO Updates Guidance on Inventorship in AI-assisted Inventions By Randy Pummill USPTO Director Squires released updated guidance on AI-assisted inventions. The new guidance states that AI-assisted inventions are...
11/20/2025 8:59:40 PM Key Insights from TEDAI 2025 By Natasha Allen Louis Lehot Nikhil Pradhan That’s a wrap! We recently co-hosted TEDAI San Francisco, the most important global gathering for thought leadership in artificial...
10/27/2025 4:43:42 PM AI in Health Care and Biotechnology: Promise, Progress, and Challenges By Antoinette Konski Artificial intelligence (AI) is transforming health care and biotechnology, propelling advancements in drug discovery, genomics, medical...
10/24/2025 8:02:39 PM Act Fast For (Nearly) Free Expedited Examination By Courtenay Brinckerhoff The USPTO announced a new pilot program designed to help it efficiently reduce the backlog of unexamined patent applications. The...
10/21/2025 5:32:38 PM USPTO Director Takes Control of IPR and PGR Institution Decisions By Courtenay Brinckerhoff In what some are perceiving as the second blow of a one-two punch against patent trial proceedings conducted at the U.S. Patent and...
10/20/2025 6:02:57 PM From Rare Genes to Precision Health: $80M in New NIH Funding to Study Longer, Healthier Lives By Antoinette Konski The Long Life Family Study (LLFS) is a multi-decade, multicenter research program designed to uncover the genetic and biological factors...
10/16/2025 8:55:25 PM USPTO Issues Proposed Rulemaking On Discretionary Denials of IPR Proceedings By Courtenay Brinckerhoff In the first proposed rulemaking issued under Director Squires, the USPTO proposes to modify the rules of practice relating to...
10/9/2025 5:52:46 PM California Governor Newsom Signs Browser Opt-out Signal Bill By Steve Millendorf On October 8, California Governor Newsom signed AB 566, which adds a section to the California Privacy Protection Agency (CCPA) to...
10/9/2025 4:22:11 PM Will You Help The USPTO Test AI-Generated Prior Art Searching? By Courtenay Brinckerhoff One of the goals of the new Director of the United States Patent and Trademark Office (USPTO) is to improve patent examination efficiency...
10/8/2025 2:58:09 PM From Abstract to Applied: How Desjardins Can Reframe Patent Protection for AI in Health Care By Antoinette Konski Evan Glass For a decade, innovators at the intersection of artificial intelligence (AI) and precision medicine have faced a stubborn paradox: the...
9/29/2025 1:42:09 PM From Patent to Patient: FDA Policy Ideas to Protect and Speed Medical Innovation By Antoinette Konski A Blueprint for FDA: Recommendations to Improve Innovation and Access [1] (FDA Blueprint) is a timely white paper authored by University...
9/4/2025 5:20:39 PM Federal Circuit Skeptical of Prosecution Laches By Courtenay Brinckerhoff In Google v. Sonos, the Federal Circuit soundly disposed of arguments that the patent-in-suit was unenforceable due to laches based on an...
8/21/2025 3:36:11 PM Securing Value: Patent Strategies for AI-Accelerated Drug Repurposing By Oyvind Dahle Drug development can be slow, costly, and risky, often taking more than a decade and billions of dollars to bring a single therapy to the...